儿童与成人系统性红斑狼疮的临床特点分析
Clinical Characteristics of Systemic Lupus Erythematosus in Children and Adults
摘要: 目的:探讨儿童与成人系统性红斑狼疮(systemic lupus erythematosus, SLE)临床表现及实验室指标的差异。方法:收集2013年4月~2017年6月在青岛大学附属医院首诊为系统性红斑狼疮患者,根据起病年龄分为儿童组(≤14岁)和成人组(>15岁),分别进行组间临床表现、实验室指标、受累系统数量、SLEDAI (systemic lupus erythematosus disease activity index, SLEDAI)评分的比较。结果:共纳入108例SLE患者,成人组67例,儿童组41例。儿童组与成人组相比,颜面皮疹(68.3%/37.3%)、肌炎(14.6%/3.0%)、消化系统受累(36.6%/9.0%)、精神神经系统症状(29.2%/9.0%)、合并感染(65.9%/44.8%)的发生率差异有统计学差异(P < 0.05)。儿童组受累器官更多(t = 2.27),SLEDAI评分更高(t = 2.03),成人组与儿童组相比,呼吸系统受累率(56.7%/14.1%)差异有统计学意义(P < 0.05)。结论:成人与儿童SLE存在相似之处,但儿童SLE受累系统更多,临床表现更重。
Abstract: Objective: To explore the difference of clinical manifestations and laboratory data between children and adults with systemic lupus erythematosus (SLE). Methods: Collected the clinical information of patients with systemic lupus erythematosus who were first diagnosed in the Affiliated Hospital of Qingdao University from April 2013 to June 2017. The patients were divided into children group (≤14 years old) and adults group (>15 years old) according to the onset age. The clinical manifestations, laboratory data, number of affected systems and SLEDAI (systemic lupus ery-thematosus disease activity index) scores were compared between groups. Results: A total of 108 SLE patients were enrolled, including 67 adults and 41 children. Compared with the adults group, there was a statistically significant difference in facial rash (68.3%/37.3%), myositis (14.6%/3.0%), involved digestive system (36.6%/9.0%), neuropsychiatric symptoms (29.2%/9.0%) and the in-cidence of infection (65.9%/44.8%) (P < 0.05). The children group had more organs involved (t = 2.27), and the SLEDAI score was higher (t = 2.03), indicating that the child’s condition was more serious. Conclusion: There are similarities between adults and children with SLE, but children with SLE have more involved systems and more clinical manifestations.
文章引用:荆欣欣, 王大海, 郭兴青, 林毅, 张秋业. 儿童与成人系统性红斑狼疮的临床特点分析[J]. 临床医学进展, 2019, 9(1): 80-87. https://doi.org/10.12677/ACM.2019.91014

参考文献

[1] 中华医学会儿科学分会免疫学组,《中华儿科杂志》编辑委员会. 儿童系统性红斑狼疮诊疗建议[J]. 中华儿科杂志, 2011, 49(7): 506-514.
[2] 中华医学会风湿病学分会. 系统性红斑狼疮诊治指南(草案) [J]. 中华风湿病学杂志, 2003, 7(8): 508-513.
[3] Hochberg, M.C. (1997) Updating the American College of Rheumatology Revised Cri-teria for the Classification of Systemic Lupus Erythematosus. Arthritis and Rheumatism, 40, 1725. [Google Scholar] [CrossRef] [PubMed]
[4] Cook, R.J., Gladman, D.D., Pericak, D., et al. (2000) Prediction of Short Term Mortality in Systemic Lupus Erythematosus with Time Dependent Measures of Disease Activity. The Journal of Rheumatology, 27, 1892-1895.
[5] Groot, N., Shaikhani, D., Teng, Y.K.O., et al. (2018) Long-Term Clin-ical Outcomes in a Cohort of Adults with Childhood-Onset Systemic Lupus Erythematosus. Arthritis & Rheumatology. [Google Scholar] [CrossRef] [PubMed]
[6] Mousa, T.G., Omar, H.H., Emad, R., et al. (2018) The Association of CD40 Polymorphism (rs1883832C/T) and Soluble CD40 with the Risk of Systemic Lupus Erythematosus among Egyptian Patients. Clinical Rheumatology. [Google Scholar] [CrossRef] [PubMed]
[7] Ciccacci, C., Perricone, C., Ceccarelli, F., et al. (2014) A Multi-locus Genetic Study in a Cohort of Italian SLE Patients Confirms the Association with STAT4 Gene and Describes a New Association with HCP5 Gene. PLoS One, 9, e111991. [Google Scholar] [CrossRef] [PubMed]
[8] Marks, S.D. and Tullus, K. (2012) Autoantibodies in Systemic Lupus Erythematosus. Pediatric Nephrology, 27, 1855-1868. [Google Scholar] [CrossRef] [PubMed]
[9] Mireles-Canales, M.P., Gonzalez-Chavez, S.A., Quinonez-Flores, C.M., et al. (2018) DNA Damage and Deficiencies in the Mechanisms of Its Repair: Implications in the Pathogenesis of Systemic Lupus Erythematosus. Journal of Immunology Research, 2018, 8214379. [Google Scholar] [CrossRef] [PubMed]
[10] 潘延斌, 李建民, 刘京平, 林有坤. 首诊儿童与成人系统性红斑狼疮病例的临床比较分析[J]. 广西医科大学学报, 2011, 28(5): 729-731.
[11] 尧雨根. 儿童与成人系统性红斑狼疮的临床特点比较[J]. 海南医学, 2012, 23(22): 84-85.
[12] Chowichian, M., Aanpreung, P., Pongpaibul, A., et al. (2018) Lupus Enteritis as the Sole Presenting Feature of Systemic Lupus Erythematosus: Case Report and Review of the Literature. Paediatrics and International Child Health, 1-5. [Google Scholar] [CrossRef] [PubMed]
[13] Liu, Y., Zhu, J., Lai, J.M., et al. (2018) Reports of Three Cases with the Initial Presentation of Mesenteric Vasculitis in Children with System Lupus Erythematous. Clinical Rheumatology, 37, 277-283. [Google Scholar] [CrossRef] [PubMed]
[14] Soybilgic, A. (2015) Neuropsychiatric Systemic Lupus Erythe-matosus in Children. Pediatric Annals, 44, e153-e158. [Google Scholar] [CrossRef] [PubMed]
[15] Sit, J.K.K. and Chan, W.K.Y. (2018) Risk Factors for Damage in Childhood-Onset Systemic Lupus Erythematosus in Asians: A Case Control Study. Pediatric Rheumatology, 16.
[16] Kalinowska-Lyszczarz, A., Pawlak, M.A., Wyciszkiewicz, A., et al. (2017) Immune Cell Neurotrophin Production Is Associated with Subcortical Brain Atrophy in Neuropsychiatric Systemic Lupus Erythematosus Patients. Neuroimmunomodulation, 24, 320-330. [Google Scholar] [CrossRef] [PubMed]
[17] Hawro, T., Bogucki, A., Krupinska-Kun, M., et al. (2015) Serum Neuron Specific Enolase—A Novel Indicator for Neuropsychiatric Systemic Lupus Erythematosus? Lupus, 24, 1492-1497. [Google Scholar] [CrossRef] [PubMed]
[18] Monov, S., Hris-tova, R., Dacheva, R., et al. (2017) Acute Necrotizing Retinal Vasculitis as Onset of Systemic Lupus Erythematosus: A Case Report. Medicine (Baltimore), 96, e5754. [Google Scholar] [CrossRef
[19] Kaul, A., Agrawal, V., Bhaduaria, D., et al. (2017) Vasculitis and Vasculopathy in Lupus Nephritis: Clinical Variability, Outcome, and New Insight into Treatment. Saudi Journal of Kidney Disease and Transplantation, 28, 415-424. [Google Scholar] [CrossRef] [PubMed]
[20] Gheita, T.A., Abaza, N.M., Sayed, S., et al. (2017) Cutaneous Vasculitis in Systemic Lupus Erythematosus Patients: Potential Key Players and Implications. Lupus.
[21] Lee, P.Y., Yeh, K.W., Yao, T.C., et al. (2013) The Outcome of Patients with Renal Involvement in Pediatric-Onset Systemic Lupus Erythematosus—A 20-Year Experience in Asia. Lupus, 22, 1534-1540. [Google Scholar] [CrossRef] [PubMed]
[22] Mok, C.C. (2018) Systemic Lupus Erythematosus: What Should Family Physicians Know in 2018? Hong Kong Medical Journal, 24, 501-511. [Google Scholar] [CrossRef] [PubMed]
[23] Teixeira, A.R., Rodrigues, M., Guimaraes, H., et al. (2017) Neonatal Lupus—Case Series of a Tertiary Hospital. Acta Reumatológica Portuguesa, 42, 318-323.
[24] He, Y. and Sawalha, A.H. (2018) Drug-Induced Lupus Erythematosus: An Update on Drugs and Mechanisms. Current Opinion in Rheuma-tology, 30, 490-497. [Google Scholar] [CrossRef
[25] Vaglio, A., Grayson, P.C., Fenaroli, P., et al. (2018) Drug-Induced Lupus: Traditional and New Concepts. Autoimmunity Reviews, 17, 912-918. [Google Scholar] [CrossRef] [PubMed]
[26] 秦凤, 于清, 曹兰芳, 卢燕鸣. 儿童系统性红斑狼疮合并感染86例的临床分析[J]. 现代生物医学进展, 2017, 17(2): 260-264.
[27] 文振华, 左晓霞, 周亚欧. 儿童与成人系统性红斑狼疮的临床和免疫学特征比较[J]. 临床误诊误治, 2012, 25(10): 64-66.
[28] Merola, J.F., Bermas, B., Lu, B., et al. (2014) Clinical Manifestations and Survival among Adults with (SLE) According to Age at Diagnosis. Lupus, 23, 778-784. [Google Scholar] [CrossRef] [PubMed]
[29] Huang, J.L., Yeh, K.W., Yao, T.C., et al. (2010) Pediatric Lupus in Asia. Lupus, 19, 1414-1418. [Google Scholar] [CrossRef] [PubMed]
[30] Brunner, H.I., Huggins, J. and Klein-Gitelman, M.S. (2011) Pe-diatric SLE—Towards a Comprehensive Management Plan. Nature Reviews Rheumatology, 7, 225-233. [Google Scholar] [CrossRef] [PubMed]
[31] Groot, N., de Graeff, N., Avcin, T., et al. (2017) European Evi-dence-Based Recommendations for Diagnosis and Treatment of Childhood-Onset Systemic Lupus Erythematosus: The SHARE Initiative. Annals of the Rheumatic Diseases, 76, 1788-1796. [Google Scholar] [CrossRef] [PubMed]
[32] Kleinmann, J.F., Tubach, F., Le Guern, V., et al. (2017) International and Multidisciplinary Expert Recommendations for the Use of Biologics in Systemic Lupus Erythematosus. Autoimmunity Reviews, 16, 650-657. [Google Scholar] [CrossRef] [PubMed]